ANTITRUST POLICY

Appointments

Antitrust Modernization Commission, S87 [7JA], S2872 [26FE]

Bills and resolutions

Copyrights: promote effective enforcement (see S. 1933), S15573 [22NO]

Drugs: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (see S. 946), S5484 [29AP]

Government regulations: encourage standards development organizations to develop and promulgate voluntary consensus standards (see S. 1799), S13660 [30OC] (see H.R. 1086), H1640 [5MR]

Health: application of antitrust laws to labor negotiations by groups of health care professionals with HMO's (see H.R. 1247), H1811 [12MR]

———clarify application of antitrust laws to negotiations between groups of health care professionals and health care insurance issuers (see H.R. 1120), H1679 [6MR]

Insurance: ensure that commercial insurers cannot engage in price fixing, bid rigging, or market allocations to the detriment of competition and consumers (see S. 352), S2187 [11FE]

———modify antitrust exemption for medical malpractice insurance, address current health care provider issues, and reform medical malpractice litigation process and insurance market (see H.R. 1158), H1680 [6MR]

———modify antitrust exemption for the insurance industry (see H.R. 448), H242 [29JA]

Law enforcement: implement antitrust enforcement enhancements and cooperation incentives (see S. 1797), S13516 [29OC]

———increase certain antitrust penalties on individuals and corporations and repeal the U.S. Antidumping Act (see S. 1080), S6624 [19MY]

Petroleum: enhance FTC or Dept. of Justice authority to prevent anticompetitive practices in tightly concentrated gasoline markets (see S. 1737), S12607 [15OC]

Public utilities: revise regulatory policies governing public utility holding companies (see H.R. 1627), H2821 [3AP]

Letters

Antitrust penalties on individuals and corporations and repeal the U.S. Antidumping Act: John Ashcroft, Attorney General and Robert B. Zoellick, U.S. Trade Representative, S6632 [19MY]

Enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs: Timothy J. Muris, FTC, S15886 [25NO]

FERC authority to review public utility mergers: Richard L. Weill, MBIA Insurance Corp., S10123 [29JY]

Remarks in House

FCC: amend media ownership rules, H3538 [30AP], H3965 [9MY]

Government regulations: encourage standards development organizations to develop and promulgate voluntary consensus standards (H.R. 1086), H5104-H5106 [10JN]

———encourage standards development organizations to develop and promulgate voluntary consensus standards (H.R. 1086), permission to file supplemental report, H4922 [4JN]

Health: application of antitrust laws to labor negotiations by groups of health care professionals with HMO's (H.R. 1247), H1859 [13MR], E436 [12MR]

———clarify application of antitrust laws to negotiations between groups of health care professionals and health care insurance issuers (H.R. 1120), E395 [7MR]

Insurance: modify antitrust exemption for medical malpractice insurance, address current health care provider issues, and reform medical malpractice litigation process and insurance market (H.R. 1158), E406 [7MR]

———modify antitrust exemption for the insurance industry, H10440 [5NO]

Public utilities: revise regulatory policies governing public utility holding companies (H.R. 1627), E664 [3AP]

Remarks in Senate

Copyrights: promote effective enforcement, S16157 [9DE]

———promote effective enforcement (S. 1933), S15573 [22NO]

Dept. of Justice: enforcement of antitrust laws relative to pork processing industry acquisitions by Smithfield Foods, Inc., S12600 [15OC]

Drugs: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs, S8012 [18JN], S8351 [23JN], S8429, S8431 [24JN], S8692 [26JN], S15884-S15886 [25NO]

———enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (S. 946), S5493, S5494 [29AP]

FERC: improve authority to review public utility mergers, S10117-S10124 [29JY], S10213, S10214 [30JY]

FTC: address issue of anticompetitive practices in the oil industry, S3049 [4MR]

Insurance: ensure that commercial insurers cannot engage in price fixing, bid rigging, or market allocations to the detriment of competition and consumers (S. 352), S2210 [11FE], S9080 [9JY]

Law enforcement: implement antitrust enforcement enhancements and cooperation incentives (S. 1797), S13520 [29OC]

———increase certain antitrust penalties on individuals and corporations and repeal the U.S. Antidumping Act (S. 1080), S6631, S6632 [19MY]

Pate, R. Hewitt: nomination to be Assistant Attorney General for the Antitrust Division, S7866-S7868 [13JN]

Petroleum: enhance FTC or Dept. of Justice authority to prevent anticompetitive practices in tightly concentrated gasoline markets (S. 1737), S12621 [15OC]

Reports filed

Nomination of R. Hewitt Pate To Be Assistant Attorney General for the Antitrust Division: Committee on the Judiciary (Senate), S7476 [5JN]

Standards Development Organization Advancement Act: Committee on the Judiciary (House) (H.R. 1086) (H. Rept. 108-125), H4733 [22MY], H4976 [4JN]

———Committee on the Judiciary (Senate) (H.R. 1086), S14176 [6NO]

Statements

FERC Authority To Review Public Utility Mergers: Executive Office of the President, S10123 [29JY]

Texts of

H.R. 1086, Standards Development Organization Advancement Act, H5104 [10JN]